HomeCompareMEDS vs QSR

MEDS vs QSR: Dividend Comparison 2026

MEDS yields 125.16% · QSR yields 3.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDS wins by $10.34M in total portfolio value
10 years
MEDS
MEDS
● Live price
125.16%
Share price
$7.59
Annual div
$9.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.37M
Annual income
$4,031,270.48
Full MEDS calculator →
QSR
QSR
● Live price
3.40%
Share price
$73.90
Annual div
$2.51
5Y div CAGR
-0.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.7K
Annual income
$386.99
Full QSR calculator →

Portfolio growth — MEDS vs QSR

📍 MEDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDSQSR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDS + QSR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDS pays
QSR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDS
Annual income on $10K today (after 15% tax)
$10,639.00/yr
After 10yr DRIP, annual income (after tax)
$3,426,579.91/yr
QSR
Annual income on $10K today (after 15% tax)
$288.70/yr
After 10yr DRIP, annual income (after tax)
$328.94/yr
At 15% tax rate, MEDS beats the other by $3,426,250.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDS + QSR for your $10,000?

MEDS: 50%QSR: 50%
100% QSR50/50100% MEDS
Portfolio after 10yr
$5.20M
Annual income
$2,015,828.73/yr
Blended yield
38.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on QSR right now

MEDS
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
-3.0
Piotroski
5/9
QSR
Analyst Ratings
27
Buy
15
Hold
2
Sell
Consensus: Buy
Price Target
$81.57
+10.4% upside vs current
Range: $71.00 — $90.00
Altman Z
1.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDS buys
0
QSR buys
0
No recent congressional trades found for MEDS or QSR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDSQSR
Forward yield125.16%3.40%
Annual dividend / share$9.50$2.51
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-0.8%
Portfolio after 10y$10.37M$24.7K
Annual income after 10y$4,031,270.48$386.99
Total dividends collected$9.46M$3.7K
Payment frequencyquarterlyquarterly
SectorStockStock
Analyst consensusBuyBuy

Year-by-year: MEDS vs QSR ($10,000, DRIP)

YearMEDS PortfolioMEDS Income/yrQSR PortfolioQSR Income/yrGap
1← crossover$23,216$12,516.47$11,037$336.93+$12.2KMEDS
2$51,999$27,157.78$12,154$344.76+$39.8KMEDS
3$112,487$56,847.66$13,357$351.99+$99.1KMEDS
4$235,291$114,929.87$14,651$358.62+$220.6KMEDS
5$476,435$224,673.57$16,041$364.68+$460.4KMEDS
6$934,959$425,173.83$17,534$370.18+$917.4KMEDS
7$1,780,186$779,779.50$19,136$375.14+$1.76MMEDS
8$3,292,387$1,387,588.61$20,856$379.58+$3.27MMEDS
9$5,921,260$2,398,405.13$22,699$383.52+$5.90MMEDS
10$10,367,018$4,031,270.48$24,675$386.99+$10.34MMEDS

MEDS vs QSR: Complete Analysis 2026

MEDSStock

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

Full MEDS Calculator →

QSRStock

Restaurant Brands International Inc. operates as quick service restaurant company in Canada and internationally. It operates through four segments: Tim Hortons (TH), Burger King (BK), Popeyes Louisiana Kitchen (PLK), and Firehouse Subs (FHS). The company owns and franchises TH chain of donut/coffee/tea restaurants that offer blend coffee, tea, and espresso-based hot and cold specialty drinks; and fresh baked goods, including donuts, Timbits, bagels, muffins, cookies and pastries, grilled paninis, classic sandwiches, wraps, soups, and others. It is also involved in owning and franchising BK, a fast food hamburger restaurant chain, which offers flame-grilled hamburgers, chicken and other specialty sandwiches, french fries, soft drinks, and other food items; and PLK quick service restaurants that provide Louisiana style fried chicken, chicken tenders, fried shrimp and other seafood, red beans and rice, and other regional items. In addition, the company owns and franchises FHS restaurants quick service restaurants that offer subs, soft drinks, and local specialties. As of February 15, 2022, the company had approximately 29,000 restaurants in 100 countries under the Tim Hortons, Burger King, Popeyes, And Firehouse Subs brands. Restaurant Brands International Inc. was founded in 1954 and is headquartered in Toronto, Canada.

Full QSR Calculator →
📬

Get this MEDS vs QSR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDS vs SCHDMEDS vs JEPIMEDS vs OMEDS vs KOMEDS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.